• Thumbnail for Bristol Myers Squibb
    The Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb (BMS), is an American multinational pharmaceutical company. Headquartered in Princeton...
    96 KB (7,620 words) - 18:57, 12 September 2024
  • Thumbnail for The Bristol-Myers Squibb Children's Hospital
    The Bristol-Myers Squibb Children's Hospital at Robert Wood Johnson University Hospital (BMSCH) is a freestanding, 68-bed pediatric acute care children's...
    37 KB (2,630 words) - 18:49, 26 August 2024
  • "Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2023" (PDF). "Bristol Myers Squibb Q4 2022 Results" (PDF). "Bristol Myers...
    62 KB (2,735 words) - 16:33, 29 August 2024
  • Between 1977 and 2006, the Bristol-Myers Squibb Foundation presented annual awards of US$50,000 to scientists for distinguished achievements in fields...
    9 KB (124 words) - 00:50, 5 February 2024
  • growth was delayed by approximately 4.1 months. In September 2001, Bristol-Myers Squibb committed $2 billion (including a $1 billion up-front cash payment)...
    20 KB (2,186 words) - 18:24, 3 August 2024
  • Bristol-Myers Squibb Co. v. Superior Court of California, San Francisco County, 582 U.S. ___ (2017), was a United States Supreme Court case in which the...
    10 KB (1,108 words) - 19:26, 7 September 2024
  • William McLaren Bristol (28 July 1860 – 1935) was one of the two co-founders of Bristol-Myers, now part of Bristol-Myers Squibb. Myers and Bristol founded the...
    2 KB (158 words) - 06:30, 24 May 2022
  • Thumbnail for John Ripley Myers
    as Bristol-Myers Squibb. Bristol-Myers Squibb is one of the largest pharmaceutical companies in the world. Myers' stepmother, Mary Ware Hewitt Myers (1848–1942)...
    7 KB (721 words) - 03:50, 21 June 2023
  • treatment. In June 2022, Owkin entered a strategic alliance with Bristol-Myers Squibb to help them design potentially more precise and efficient clinical...
    21 KB (1,806 words) - 09:58, 6 September 2024
  • Thumbnail for Deucravacitinib
    Deucravacitinib (category Drugs developed by Bristol Myers Squibb)
    2 (TYK2) inhibitor and it is taken by mouth. It was developed by Bristol Myers Squibb. Deucravacitinib was approved for medical use in the United States...
    12 KB (697 words) - 09:25, 1 July 2024